Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis

被引:1
|
作者
Rosenfeld, Margaret [1 ,2 ,12 ]
Faino, Anna, V [2 ]
Qu, Pingping [2 ]
Onchiri, Frankline M. [2 ]
Blue, Elizabeth E. [3 ]
Collaco, Joseph M. [4 ]
Gordon, William W. [5 ]
Szczesniak, Rhonda [6 ]
Zhou, Yi-Hui [7 ,8 ,9 ]
Bamshad, Michael J. [5 ,10 ,11 ]
Gibson, Ronald L. [1 ,2 ]
机构
[1] Univ Washington, Div Pulm & Sleep Med, Dept Pediat, Seattle, WA USA
[2] Seattle Childrens Res Inst, Seattle, WA USA
[3] Univ Washington, Div Med Genet, Dept Med, Seattle, WA USA
[4] Johns Hopkins Univ, Eudowood Div Pediat Resp Sci, Sch Med, Baltimore, MD USA
[5] Univ Washington, Div Genet Med, Dept Pediat, Seattle, WA USA
[6] Cincinnati Childrens Hosp & Med Ctr, Dept Pediat, Cincinnati, OH USA
[7] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA
[8] North Carolina State Univ, Dept Stat, Raleigh, NC USA
[9] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA
[10] Seattle Childrens Hosp, Seattle, WA USA
[11] Brotman Baty Inst, Seattle, WA USA
[12] Seattle Childrens Hosp, Div Pulm & Sleep Med, 4800 Sandpoint Way NE, Seattle, WA 98105 USA
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Lung function; CLINICAL EFFECTIVENESS; FUNCTION DECLINE; YOUNG-CHILDREN; RISK-FACTORS; PEOPLE; SPIROMETRY; FEV1;
D O I
10.1016/j.jcf.2023.05.004
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) is characterized in stages: never (prior to first positive culture) to incident (first positive culture) to chronic. The association of Pa infection stage with lung function trajectory is poorly understood and the impact of age on this association has not been examined. We hypothesized that FEV1 decline would be slowest prior to Pa infection, intermediate after incident infection and greatest after chronic Pa infection.Methods: Participants in a large US prospective cohort study diagnosed with CF prior to age 3 contributed data through the U.S. CF Patient Registry. Cubic spline linear mixed effects models were used to evaluate the longitudinal association of Pa stage (never, incident, chronic using 4 different definitions) with FEV1 adjusted for relevant covariates. Models contained interaction terms between age and Pa stage.Results: 1,264 subjects born 1992-2006 provided a median 9.5 (IQR 0.25 to 15.75) years of follow up through 2017. 89% developed incident Pa; 39-58% developed chronic Pa depending on the definition. Compared to never Pa, incident Pa infection was associated with greater annual FEV1 decline and chronic Pa infection with the greatest FEV1 decline. The most rapid FEV1 decline and strongest association with Pa infection stage was seen in early adolescence (ages 12-15).Conclusions: Annual FEV1 decline worsens significantly with each Pa infection stage in children with CF. Our findings suggest that measures to prevent chronic infection, particularly during the high-risk period of early adolescence, could mitigate FEV1 decline and improve survival.(c) 2023 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:857 / 863
页数:7
相关论文
共 50 条
  • [31] Impact of Pseudomonas aeruginosa Infection on Respiratory Muscle Function in Adult Cystic Fibrosis Patients
    Magnet, Friederike Sophie
    Callegari, Jens
    Dieninghoff, Doris
    Spielmanns, Marc
    Storre, Jan Hendrik
    Schmoor, Claudia
    Windisch, Wolfram
    RESPIRATION, 2017, 93 (01) : 42 - 50
  • [32] Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis
    Blanchard, Ana C.
    Horton, Eric
    Stanojevic, Sanja
    Taylor, Louise
    Waters, Valerie
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 395 - 400
  • [33] Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis
    Stanojevic, Sanja
    Waters, Valerie
    Mathew, Joseph L.
    Taylor, Louise
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (02) : 172 - 178
  • [34] Systemic oxidative stress in children with cystic fibrosis with bacterial infection including Pseudomonas Aeruginosa
    Bennemann, Gabriela Datsch
    Machado Moreira, Emilia Addison
    Radin Pereira, Leticia Cristina
    de Freitas, Maiara Brusco
    de Oliveira, Diane
    Ventura, Julia Carvalho
    Parisotto, Eduardo Benedetti
    Franco Moreno, Yara Maria
    Santos Moraes Trindade, Erasmo Benicio
    Barbosa, Eliana
    Ludwig Neto, Norberto
    Wilhelm Filho, Danilo
    CLINICAL RESPIRATORY JOURNAL, 2022, 16 (06): : 475 - 483
  • [35] Pseudomonas aeruginosa Strain-sharing in Early Infection Among Children With Cystic Fibrosis
    Stapleton, Patrick J.
    Izydorcyzk, Conrad
    Clark, Shawn
    Blanchard, Ana
    Wang, Pauline W.
    Yau, Yvonne
    Waters, Valerie
    Guttman, David S.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2521 - E2528
  • [36] Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis
    Farrell, PM
    Shen, GH
    Splaingard, M
    Colby, CE
    Laxova, A
    Kosorok, MR
    Rock, MJ
    Mischler, EH
    PEDIATRICS, 1997, 100 (05) : E2
  • [37] Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
    Chambers, D
    Scott, F
    Bangur, R
    Davies, R
    Lim, A
    Walters, S
    Smith, G
    Pitt, T
    Stableforth, D
    Honeybourne, D
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (04) : 651 - 656
  • [38] Pseudomonas aeruginosa and cystic fibrosis:: first colonization to chronic infection
    Laurans, M.
    Arion, A.
    Fines-Guyon, M.
    Regeasse, A.
    Brouard, J.
    Leclercq, R.
    Duhamel, J. F.
    ARCHIVES DE PEDIATRIE, 2006, 13 : S22 - S29
  • [39] Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
    Park, J. E.
    Yung, R.
    Stefanowicz, D.
    Shumansky, K.
    Akhabir, L.
    Durie, P. R.
    Corey, M.
    Zielenski, J.
    Dorfman, R.
    Daley, D.
    Sandford, A. J.
    GENES AND IMMUNITY, 2011, 12 (05) : 370 - 377
  • [40] Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
    J E Park
    R Yung
    D Stefanowicz
    K Shumansky
    L Akhabir
    P R Durie
    M Corey
    J Zielenski
    R Dorfman
    D Daley
    A J Sandford
    Genes & Immunity, 2011, 12 : 370 - 377